1,334 followers
RT @AkashPatnaik7: Thrilled to share our recent publication highlighting a neutrophil-based nanoimmunotherapeutic strategy to enhance paylo…
1,008 followers
RT @AkashPatnaik7: Thrilled to share our recent publication highlighting a neutrophil-based nanoimmunotherapeutic strategy to enhance paylo…
552 followers
RT @AkashPatnaik7: Thrilled to share our recent publication highlighting a neutrophil-based nanoimmunotherapeutic strategy to enhance paylo…
1,821 followers
Great to see this out from the @AkashPatnaik7 lab. Cabozantinib-induced nanoparticle delivery in a PTEN and p53 deficient prostate cancer model.
325 followers
Thrilled to share our recent publication highlighting a neutrophil-based nanoimmunotherapeutic strategy to enhance payload delivery to cancers. Cross-talk between tumor immunologists and chemical engineers within our team was critical to make this happen!
767 followers
Cabozantinib unlocks efficient in vivo targeted delivery of neutrophil-loaded nanoparticles into murine prostate tumors. 𝙈𝙤𝙡 𝘾𝙖𝙣𝙘𝙚𝙧 𝙏𝙝𝙚𝙧. #ProstateCancer https://t.co/d7Dbqt9lYn
3,787 followers
A wonderful collaboration with Akash Patnaik's lab at UChicago and colleagues at Beth Israel - Cabozantinib unlocks efficient in vivo targeted delivery of neutrophil-loaded nanoparticles into murine prostate tumors https://t.co/6ehtrAxD34